AOR Launches US Website Business to Customers
CALGARY, ALTA – AOR has launched direct product sales and distribution online for the US markets, beginning this January, 2018. Products will now be offered for sale directly from the AOR website for US customers. This direct advantage offers shoppers with lower pricing, flat rates for shipping, free shipping on orders over $150, direct access to customer care and shipments received in 3-5 business days. Customers can also watch the website for special offers and coming soon a loyalty program.
“AOR is the most trusted supplement brand on the market for a reason; we deliver the right molecule, at the right dose at the right place at the right time. And now, our US based customers can purchase our products directly online, from the comfort of your own home” says Pran Nibber, AOR’s General Manager.
AOR offers customers a unique and truly orthomolecular approach to personalized nutrition, meaning that they can choose a formulation that best suits their individual needs. AOR also understands that because each person’s body chemistry is unique, the same dose or ingredient may not work for everyone. That’s why AOR offers such a vast array of formulas for similar health concerns.
Advanced Orthomolecular Research (AOR), a Canadian-based company with headquarters in Calgary, Alberta, has an established reputation in Canada as the most advanced supplement formulator in the country and likely, the world. At AOR, we believe that truth and transparency are the most important values for any organization to uphold. It is through ethical discipline and evidenced-based science that we lead and advance the natural health industry. As visionaries, we seek to catalyze change and challenge conventions through continuous innovation. We exist to create safe, effective, and therapeutic solutions from nature herself, so you can always trust that we deliver the right molecule in the right dose, at the right place, at the right time.
For more information, please visit: www.aor.us
US Director, AOR Inc.